ACE2 and infection: On the other hand, developing in-vitro and in-vivo models including conditional double transgenic/knockout of ACE-2 and TMPRSS2 could be one of best models to understand to role of these genes in the infection process which also can help to develop new therapies based on the shutdown of one or both of these genes.